Corcept Therapeutics Earnings
NASDAQ: CORTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 121.19 0.00%
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$0.68
Corcept Therapeutics earnings summary
Corcept Therapeutics is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $0.68. In its most recent report on Jul 29, 2026 (Q2 2026), CORT posted EPS of $0.36. Revenue for the quarter was $256.1 million.
Quarterly EPS is up 24.1% from the same quarter a year earlier. Across the last 16 reports, CORT shares moved an average of 5.6% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
CORT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 29, 2026 | — | $0.36 | — | -3.2% |
| Apr 30, 2026 | — | $-0.30 | — | +1.7% |
| Feb 24, 2026 | — | $0.20 | — | -5.1% |
| Nov 4, 2025 | — | $0.16 | — | +2.5% |
| Jul 31, 2025 | — | $0.29 | — | +4.8% |
| May 5, 2025 | — | $0.17 | — | +6.9% |
| Feb 26, 2025 | — | $0.25 | — | -8.6% |
| Oct 30, 2024 | — | $0.41 | — | +25.2% |
| Jul 29, 2024 | — | $0.32 | — | -3.1% |
| May 1, 2024 | — | $0.25 | — | +10.3% |
| Feb 15, 2024 | — | $0.27 | — | -1.1% |
| Nov 1, 2023 | — | $0.28 | — | -2.3% |
| Aug 2, 2023 | — | $0.25 | — | -1.0% |
| May 3, 2023 | — | $0.14 | — | -1.8% |
| Feb 28, 2023 | — | $0.13 | — | +7.8% |
| Nov 3, 2022 | — | $0.30 | — | +3.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.